Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol versus placebo during febrile neutropenia after intensive chemotherapy
ACTRN12613000601730Phase 2Completed
- Sponsor
- Malaghan Institute of Medical Research
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in febrile neutropenia (FN) comparing Paracetamol with Placebo (2 arms). Primary endpoint: Successful treatment by 72 hours. Started Oct 2013; status: completed.
02
Drugs
acetaminophen
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on ACTRN12613000601730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000601730.